Under the collaboration, Phlow will produce the U.S.-based API, while Fresenius Kabi will manufacture the finished doses for ...

Phlow will manufacture epinephrine API in Virginia while Fresenius Kabi formulates and fills finished doses in existing US ...

Fresenius Kabi and Phlow Corp. announced today a first-of-its-kind collaboration to onshore the manufacture of Epinephrine Injection, USP, an essential medicine long at risk of chronic shortage in the ...

Fresenius Kabi and Phlow Corp. have joined forces to onshore the manufacture of Epinephrine Injection, USP in the U.S.

Please provide your email address to receive an email when new articles are posted on . Researchers captured patient and caregiver expected anxiety and well-being with different epinephrine treatment ...

Several universities across the country keep undesignated stock epinephrine in their dining halls, providing a critical medication for students facing severe allergic reactions to food. The University ...

Epinephrine nasal spray works well even if patients sniff while using it, according to an abstract presented at the American College of Allergy, Asthma, and Immunology (ACAAI) 2025 Annual Meeting in ...

An initial dose of 0.3 mg intramuscular (IM) epinephrine was tied to a greater escalation of care than a dose of 0.5 mg in patients with anaphylaxis, a retrospective single-center study found. The ...

Frustrated that the U.S. had so many medications on the Food and Drug Administration’s drug-shortage list, Edwards partnered in 2020 with Frank Gupton, a Virginia Commonwealth University professor, to ...